Siddharth J. Modi

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

Siddharth J. Modi, Vithal M. Kulkarni · Medicine in Drug Discovery · 2019 · 318 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)

Siddharth J. Modi, Anshuly Tiwari, Chetana Ghule et al. · Molecules · 2022 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma

Siddharth J. Modi, Vithal M. Kulkarni · European Journal of Medicinal Chemistry · 2020 · 36 citations

Medicine, Oncology, Pharmacology +17

Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis

V. G. Vaidya, Ninad Naik, Gayatri Ganu et al. · Journal of Ethnopharmacology · 2023 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +5

Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers

V. G. Vaidya, Amol Gothwad, Gayatri Ganu et al. · Journal of Ayurveda and Integrative Medicine · 2023 · 29 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +8